References
- Abdel-Aziz AA-M, Asiri YA, El-Azab AS, Al-Omar MA, Kunieda T. 2011. Tadalafil. In: Brittain HG, editor. Profiles of drug substances, excipients, and related methodology. Amsterdam: Elsevier Inc.; p. 287–329.
- Hasegawa T, Saijo M, Ishii T, Nagata T, Haishima Y, Kawahara N, Goda Y. 2008. Structural elucidation of a tadalafil analogue found in a dietary supplement. J Food Hyg Soc Jpn (Shokuhin Eiseigaku Zasshi). 49:311–315.
- Huang Y-C, Lee H-C, Lin Y-L, Li C-Y, Tsai C-F, Cheng H-F. 2016a. Separation and identification of a novel tadalafil analogue adulterant in a dietary supplement. Food Addit Contam Part A. 33:179–185.
- Huang Y-C, Lee H-C, Lin Y-L, Li C-Y, Tsai C-F, Cheng H-F. 2016b. Identification of a new tadalafil analogue, dipropylaminopretadalafil, in a dietary supplement food addit. Contam Part A. 33:953–958.
- Kee C-L, Ge X, Gilard V, Malet-Martino M, Low M-Y. 2017. A review of synthetic phosphodiesterase type 5 inhibitors (PDE-5i) found as adulterants in dietary supplements. J Pharm Biomed Anal. 87:176–190.
- Lin M-C, Liu Y-C, Lin Y-L, Lin J-H. 2009. Identification of a tadalafil analogue adulterated in a dietary supplement. J Food Drug Anal. 17:451–458.
- [TFDA] Taiwan Food and Drug Administration. 2012. Method of test for adulterants in Chinese medicine and foods (no. TFDAO0015.01). [accessed 2012 Nov 23]. http://www.fda.gov.tw/upload/133/Content/2012112316074585170.pdf.
- Zou P, Hou P, Low MY, Koh HL. 2006. Structural elucidation of a tadalafil analogue found as an adulterant of a herbal product. Food Addit Contam. 23:446–451.